• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, July 5, 2022
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Initiate ‘reduce’ on Divi’s Labs with FV of Rs 3,000

by The Outlooker Web Desk
November 21, 2020
in Business
0
Initiate ‘reduce’ on Divi’s Labs with FV of Rs 3,000
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Over the years, Divi’s has emerged as a partner of choice for several of its key Big Pharma customers for synthesis
projects, with expertise in scaling up high tonnage products.

Divi’s has built a global leadership across its API portfolio, and we expect it to benefit from a shift in global supply
chains, driving 20% CAGR over FY2020- 23E. However, for the synthesis segment, our analysis of over >350 NCEs
suggests a steep and continued decline in peak tonnage requirements over time, with the opportunity from new product introductions over CY2016-18 to be only $450 million, across 60 launches.

At ~35X FY2023E EPS, we believe the stock fully captures the generics growth, while ignoring the emerging headwinds to the higher valued synthesis business. We initiate with ‘reduce’ rating, and Fair Value of Rs 3,000/share.

Over the years, Divi’s has emerged as a partner of choice for several of its key Big Pharma customers for synthesis
projects, with expertise in scaling up high tonnage products. Despite a nearterm benefit from fast-track development of certain customer projects, largely for Covid- 19 treatments, in our view, we see risks of a significant slowdown in growth over the longer term. Our deep dive, bottom-up analysis of >350 NCEs launched post CY2000 indicates a continued and steep decline in tonnage requirements, with the trend in particular accelerating post CY2015. For example, CY2016-18 NCE launches are only likely to have a peak global API requirement of 113 tons (average: 2 tons), a sharp decline compared to 5,192 tons for CY2001-10 launches, thereby bringing down the addressable opportunity from new product introductions to $450 million, with no product in the >$25 million opportunity bucket. Even as we expect the segment to grow 15% CAGR over FY2020-23E, we expect the growth rate
to moderate to high-single digits from FY2023E, and expect contribution to decline to 38% of revenues by FY2023E
from 41% in FY2020, and down from peak of 51% in FY2016.

Divi’s has emerged as a dominant, independentAPI provider globally, with leading market shares globally for 11
APIs, and dominant market share in several high-volume products such as naproxen, which now accounts for ~18%
of consolidated revenues.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
UP Home Department Proposes Tough Law Against ‘Love Jihad’: Report

UP Home Department Proposes Tough Law Against 'Love Jihad': Report

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Rahul Gandhi attacks BJP after Karnataka HC judge says he was threatened with transfer
Politics

Rahul Gandhi attacks BJP after Karnataka HC judge says he was threatened with transfer

July 5, 2022
In 2nd Spicejet Incident Today, Windshield Cracks On Gujarat-Mumbai Flight
National

In 2nd Spicejet Incident Today, Windshield Cracks On Gujarat-Mumbai Flight

July 5, 2022
PDP demands high-level probe against BJP leadership for 'sheltering' LeT terrorist
Politics

PDP demands high-level probe against BJP leadership for 'sheltering' LeT terrorist

July 5, 2022
Nifty, Sensex erase intraday gains to end in red amid high volatility; ‘use dips to buy quality stocks’
Business

Nifty, Sensex erase intraday gains to end in red amid high volatility; ‘use dips to buy quality stocks’

July 5, 2022

Connect with us

No Result
View All Result

Archives

  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Rahul Gandhi attacks BJP after Karnataka HC judge says he was threatened with transfer
  • In 2nd Spicejet Incident Today, Windshield Cracks On Gujarat-Mumbai Flight
  • PDP demands high-level probe against BJP leadership for 'sheltering' LeT terrorist

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.